Methods for Detection of Nucleotide Modification
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 2 of these applications claim priority to application PCT/GB2012/051819, filed Jul 27, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,290,807 | Methods for Detection of Nucleotide Modification In force · High confidence UsedRemaining | Biomodal Limited | In force | High confidence | ||
| US 10,428,381 | Methods for Detection of Nucleotide Modification In force · High confidence | Biomodal Limited | In force | High confidence | ||
| Application 18/500,326 | Methods for Detection of Nucelotide Modification Abandoned Abandoned Jul 23, 2024 | Biomodal Limited | Abandoned | Abandoned Jul 23, 2024 | ||
| Application 18/773,990 | Methods for Detection of Nucelotide Modification Abandoned Abandoned Mar 3, 2025 | Biomodal Limited | Abandoned | Abandoned Mar 3, 2025 | ||
| Application 19/386,582 | Methods for Detection of Nucelotide Modification Pending Not granted | Biomodal Limited | Pending | Not granted |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Biomodal Limited.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.